Epinephrine Dosing Formula
Paediatric epinephrine dosing depends on three variables: the child's weight in kilograms, the route of administration, and the required dose per kilogram for that route. Each route has distinct absorption characteristics, necessitating different mg/kg concentrations.
The fundamental calculation is:
Dose (mg) = Weight (kg) × Dose per kg (mg/kg)
Volume (mL) = Dose (mg) ÷ Concentration (mg/mL)
Weight (kg)— Child's current weight in kilogramsRoute of administration— Method of delivery: IV, IM, SC, ET, or nebulizerDose per kg— Route-specific dose in mg/kg, determined by clinical protocol
Route-Specific Dosing Guidelines
Epinephrine dosing varies substantially by route because absorption rates and tissue distribution differ. Intravenous administration bypasses absorption barriers, so lower mg/kg doses are needed. Endotracheal delivery requires higher doses to penetrate the airway.
- Intravenous (IV): 0.01 mg/kg of 1:10,000 solution for cardiopulmonary resuscitation and shock states. Maximum single dose 1 mg.
- Intramuscular / Subcutaneous (IM/SC): 0.01 mg/kg of 1:1,000 solution for anaphylaxis and severe asthma exacerbations. Maximum 0.3–0.5 mg per dose.
- Endotracheal (ET): 0.1 mg/kg of 1:1,000 solution when IV access unavailable during resuscitation. Maximum 10 mg.
- Nebuliser: 0.5 mg/kg of 1:1,000 solution for croup and airway obstruction. Maximum 5 mg per treatment.
Solution Concentration: 1:1,000 versus 1:10,000
Two epinephrine concentrations are commonly used in paediatrics. The choice depends on route and availability, but the dose (in mg) remains constant—only the volume changes.
- 1:1,000 solution: Contains 1 mg per 1 mL. Used for IM, SC, ET, and nebuliser routes. Higher concentration means smaller injection volumes.
- 1:10,000 solution: Contains 1 mg per 10 mL. Used for IV administration and continuous infusions. Lower concentration requires 10 times the volume to deliver the same dose.
This distinction is clinically important: administering an IV dose with 1:1,000 solution would deliver 10 times the intended amount, risking severe cardiac complications.
EpiPen Dosing in Children
Automatic epinephrine auto-injectors (EpiPens) deliver fixed doses based on weight brackets, simplifying treatment of anaphylaxis outside medical settings.
- EpiPen Jr: 0.15 mg intramuscular injection for children weighing 15–30 kg (approximately 33–66 pounds).
- EpiPen (regular): 0.3 mg intramuscular injection for children and adolescents weighing ≥30 kg (≥66 pounds).
These fixed doses align with evidence-based anaphylaxis protocols. A second dose may be given 5–15 minutes after the first if symptoms persist. Always follow local guidelines, as some protocols recommend higher EpiPen doses for heavier children.
Clinical Considerations and Common Pitfalls
Accurate epinephrine dosing is life-saving, but several mistakes can compromise patient safety.
- Confusing solution concentrations — The most dangerous error is mixing up 1:1,000 and 1:10,000 solutions. Double-check the vial label and calculate volume carefully. IV routes require 1:10,000; IM/SC and nebuliser routes use 1:1,000. When in doubt, verify with a second clinician before drawing up the dose.
- Forgetting maximum doses — Age and route-specific maximum doses prevent toxicity. A 25 kg child with an IV dose would receive maximum 1 mg, not unlimited escalation. Endotracheal routes cap at 10 mg even for larger children. Reference your institution's paediatric emergency protocols during resuscitation.
- Weight estimation errors — If the child's actual weight is unknown, age-based estimates introduce cumulative error. A 10-year-old averages ~30 kg, but can range 20–45 kg depending on growth. Use scales whenever possible; formulas like (age + 4) × 2 for kg are fallback tools only, not preferred methods.
- Timing and repeat dosing — Epinephrine has a short half-life (1–2 minutes). During cardiopulmonary resuscitation, doses are repeated every 3–5 minutes. In anaphylaxis, auto-injectors can be repeated after 5–15 minutes if symptoms worsen. Frequent reassessment and clear documentation of administration times prevent overdose.